SEC Form 4 · accession 0001567619-18-002824
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Eric Davis
Officer — EVP, General Counsel
Period of report
Sep 14, 2018
Accepted (ET)
Sep 18, 2018 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2018 | S | 1,400 | $99.45 | D | 73,550 | D | |
| Common Stock | Sep 14, 2018 | S | 200 | $99.455 | D | 73,350 | D | |
| Common Stock | Sep 14, 2018 | S | 616 | $99.456 | D | 72,734 | D |
Table II — derivative securities
No Table II lines on this filing.